Skip to content

Locally Prepared Supplement to Support Growth and Brain Health

Study on a Locally Prepared Food Supplement to Support Growth and Brain Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03017209
Enrollment
1059
Registered
2017-01-11
Start date
2017-01-31
Completion date
2018-01-31
Last updated
2019-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Function, Malnutrition, Child

Brief summary

This study is a randomized controlled trial with a main goal to assess the effects of a locally-prepared food for prevention of malnutrition and stunting, in comparison with standard village practices and also a widely available aid food supplement in 8-12 villages in Guinea-Bissau. The supplement intervention will be for 24-30 weeks. The primary outcome will be cognitive tests of executive function. Secondary outcomes will be changes in standard anthropometric benchmarks of growth, hemoglobin and skin carotenoids in young children living in villages in rural Guinea-Bissau. This is a within-village randomization at the level of the family, and all children will receive a dietary intervention.

Detailed description

Up to 1050 children aged 15 months to 6.99 years, and older children if in 1st grade elementary school, in 8-12 villages in the Oio and Cachau regions of Guinea-Bissau will be recruited for this study along with their maternal caregiver and father. Child ages will be based on the official birth records which families possess. The mothers/primary caregivers and fathers of the children will also be recruited for simple outcome assessments. Villages will be a convenience sample chosen from villages within the network of our local research partner International Partnership for Human Development. Each village in this region has one school and one community health center per village, which will be involved in supplement distribution and some outcome assessments. Families with enrolling children will be randomized within 8-12 villages to receive 1 of 3 supplements and if any family (defined based on the father of the children since this is a polygamous community) has more than one enrolling child all those children will be randomized to the same supplement arm. * One supplement will be the locally-prepared bar * One will be an isocaloric amount of porridge prepared with USAIDs Corn Soy Blend Plus, prepared as recommended in a 10:3 ratio with fortified vegetable oil. * One supplement will be an isocaloric amount of cooked rice with vegetable oil, which is the typical local breakfast. Villagers will be informed of the randomization after baseline testing is complete. Following baseline measurements in children of anthropometry and body composition, grip strength, cognition, hemoglobin, and skin carotenoids, children will receive their intervention for 24-30 weeks and the same measurements taken at baseline will be repeated during the last study week. The flexible end data is given to accommodate the local rainy season and its impact on transportation. Please note that cell phone access to villages is not influenced by local weather, thus communication regarding safety issues with community health workers will remain possible throughout the entire trial. Addendum: The pre-planned primary method of analysis was a per-protocol analysis, predefined as children consuming ≥75% of their supplement. However, a clerical error in this clinical trial registration did not describe this predetermined focus on a per-protocol population. The registration implies an intention-to-treat (ITT) analysis by default. Investigators therefore revised our analytical approach to designate the ITT cohort as the primary cohort of interest. The secondary cohort of interest is the predefined per-protocol cohort (children consuming ≥75% of their supplement).

Interventions

DIETARY_SUPPLEMENTLocally-prepared bar

School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.

DIETARY_SUPPLEMENTUSAID Corn Soy Blend Plus

School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.

OTHERPlacebo

School children in first grade will receive their supplement 5 days a week in the morning before school starts. Younger children will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers. The teachers and community health workers will record amount of supplement consumption daily during the study, and will report the information weekly to the local research team throughout the intervention period.

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Global Food & Nutrition Inc.
CollaboratorOTHER
Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Months to 7 Years
Healthy volunteers
Yes

Inclusion criteria

* Parent or legal guardian provides consent for all children \<7 years and the parent plus the child provide consent for any child \> 7 years. * Age 15 months to 6.99 years old or any age enrolled in first grade in the same village. * The family plans to remain in the village for the duration of the study (up to 30 weeks) based on self-report by a parent; * The child does not have any known food allergies as reported by the mother or guardian.

Exclusion criteria

If any child is identified as malnourished at baseline, defined as a mid-upper arm circumference in the red zone of the paper tape, the child will be excluded from the study due to malnutrition, and the parents will be advised to take the child to the nearest malnutrition clinic.

Design outcomes

Primary

MeasureTime frame
Change in cognitive function measured using executive functions tasks in children ages 15 months to 3 yearsbaseline and 24-30 weeks after baseline testing

Secondary

MeasureTime frameDescription
Changes in z-scores for weight (WAZ)baseline and 24-30 weeks after baseline testing
Changes in z-scores for height (HAZ)baseline and 24-30 weeks after baseline testing
Cognitive tests for children >3 years oldbaseline and 24-30 weeks after baseline testingLooking to see changes in executive function who attend supplement distribution at least 75% of the days it is offered.
Mid-upper arm circumferencebaseline and 24-30 weeks after baseline testing
Cerebral blood flowbaseline and 24-30 weeks after baseline testingBy infrared spectroscopy
% Lean tissue and lean growthbaseline and 24-30 weeks after baseline testing
Changes in weight for height Z scoresbaseline and 24-30 weeks after baseline testing
Hemoglobinbaseline and 24-30 weeks after baseline testing

Other

MeasureTime frameDescription
Weight of female-caregivers and fathersbaseline and 24-30 weeks after baseline testing
Head circumference of childbaseline and 24-30 weeks after baseline testing
Height of female-caregivers and fathersbaseline and 24-30 weeks after baseline testing
Mid upper arm circumference of female caregiversbaseline and 24-30 weeks after baseline testing
Grip strengthbaseline and 24-30 weeks after baseline testingUsing a dynamometer
Carotenoidsbaseline and 24-30 weeks after baseline testingBy Resonance Raman Spectroscopy

Countries

Guinea-Bissau

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026